Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27710, USA.
Drug Alcohol Depend. 2010 Nov 1;112(1-2):69-80. doi: 10.1016/j.drugalcdep.2010.05.013. Epub 2010 Jul 1.
To identify subtypes of nonmedical opioid users, gender variations in psychiatric disorders, and quality of life in a representative sample of adults.
Analyses of data from the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions (N=43,093). Latent class analysis (LCA) and multinomial logistic regression procedures examined subtypes of nonmedical opioid users.
Approximately 5% (n=1815) of adults used nonmedical opioids. LCA identified four subtypes: opioid-marijuana users (33%), opioid-other prescription drug users (9%), opioid-marijuana-hallucinogen users (28%), and opioid-polydrug users (30%). Subtypes were distinguished by race/ethnicity, gender, familial substance abuse, personal history of substance abuse treatment, and patterns of psychiatric disorders. Whites and men had increased odds of being in the opioid-polydrug and opioid-marijuana-hallucinogen subtypes. The opioid-other prescription drug use subtype had disproportionately affected women who were characterized by high rates of mood/anxiety disorders and low quality of life. Across all subtypes, women and men had similarly problematic substance use disorders; however, women had more major depression and disability in the mental health domain.
The generally high prevalence of psychiatric disorders among nonmedical opioid users, particularly women, underscores the need for comprehensive assessment and coordinated delivery of services to match needs with treatment, as well as continued monitoring of trends in opioid use and related problems.
在成年人的代表性样本中,确定非医疗类阿片类药物使用者的亚组、精神障碍的性别差异以及生活质量。
对 2001-2002 年全国酒精和相关情况流行病学调查(N=43093)的数据进行分析。采用潜在类别分析(LCA)和多项逻辑回归程序,对非医疗类阿片类药物使用者的亚组进行研究。
约有 5%(n=1815)的成年人使用非医疗类阿片类药物。LCA 确定了四种亚组:阿片类药物-大麻使用者(33%)、阿片类药物-其他处方药物使用者(9%)、阿片类药物-大麻-致幻剂使用者(28%)和阿片类药物-多药物使用者(30%)。各亚组在种族/民族、性别、家族物质滥用史、个人物质滥用治疗史以及精神障碍模式方面存在差异。白人及男性更有可能属于阿片类药物-多药物和阿片类药物-大麻-致幻剂亚组。阿片类药物-其他处方药物使用亚组中,患有情绪/焦虑障碍和生活质量较低的女性比例过高。在所有亚组中,女性和男性都存在同样严重的物质使用障碍;然而,女性在心理健康领域中更易患重度抑郁症和残疾。
非医疗类阿片类药物使用者,尤其是女性,普遍存在较高的精神障碍患病率,这突出表明需要进行全面评估并协调服务的提供,以根据需要进行治疗,并持续监测阿片类药物使用和相关问题的趋势。